» Articles » PMID: 35681202

SRF: a Seriously Responsible Factor in Cardiac Development and Disease

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2022 Jun 10
PMID 35681202
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanisms that regulate embryogenesis and cardiac development are calibrated by multiple signal transduction pathways within or between different cell lineages via autocrine or paracrine mechanisms of action. The heart is the first functional organ to form during development, which highlights the importance of this organ in later stages of growth. Knowledge of the regulatory mechanisms underlying cardiac development and adult cardiac homeostasis paves the way for discovering therapeutic possibilities for cardiac disease treatment. Serum response factor (SRF) is a major transcription factor that controls both embryonic and adult cardiac development. SRF expression is needed through the duration of development, from the first mesodermal cell in a developing embryo to the last cell damaged by infarction in the myocardium. Precise regulation of SRF expression is critical for mesoderm formation and cardiac crescent formation in the embryo, and altered SRF levels lead to cardiomyopathies in the adult heart, suggesting the vital role played by SRF in cardiac development and disease. This review provides a detailed overview of SRF and its partners in their various functions and discusses the future scope and possible therapeutic potential of SRF in the cardiovascular system.

Citing Articles

Electrical Forces Improve Memory in Old Age.

McCaig C Rev Physiol Biochem Pharmacol. 2025; 187():453-520.

PMID: 39838022 DOI: 10.1007/978-3-031-68827-0_21.


Single-molecule analysis reveals that IPMK enhances the DNA-binding activity of the transcription factor SRF.

Ahn H, Yu J, Ryu K, Ryu J, Kim S, Park J Nucleic Acids Res. 2025; 53(1.

PMID: 39777465 PMC: 11704961. DOI: 10.1093/nar/gkae1281.


Leiomodin 2 neonatal dilated cardiomyopathy mutation results in altered actin gene signatures and cardiomyocyte dysfunction.

Iwanski J, Pappas C, Mayfield R, Farman G, Ahrens-Nicklas R, Churko J NPJ Regen Med. 2024; 9(1):21.

PMID: 39285234 PMC: 11405699. DOI: 10.1038/s41536-024-00366-y.


Recent advances in serum response factor posttranslational modifications and their therapeutic potential in cardiovascular and neurological diseases.

Visconti A, Qiu H Vascul Pharmacol. 2024; 156:107421.

PMID: 39209126 PMC: 11626983. DOI: 10.1016/j.vph.2024.107421.


SRF Facilitates Transcriptional Inhibition of Gem Expression by m6A Methyltransferase METTL3 to Suppress Neuronal Damage in Epilepsy.

Li L, Liu Z Mol Neurobiol. 2024; 62(3):2903-2925.

PMID: 39190265 DOI: 10.1007/s12035-024-04396-x.


References
1.
Madonna R, Geng Y, Bolli R, Rokosh G, Ferdinandy P, Patterson C . Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts. J Biol Chem. 2014; 289(28):19585-98. PMC: 4094070. DOI: 10.1074/jbc.M113.540559. View

2.
Touvron M, Escoubet B, Mericskay M, Angelini A, Lamotte L, Santini M . Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction. Dis Model Mech. 2012; 5(4):481-91. PMC: 3380711. DOI: 10.1242/dmm.009456. View

3.
Zhang X, Williams E, Azhar G, Rogers S, Wei J . Does p49/STRAP, a SRF-binding protein (SRFBP1), modulate cardiac mitochondrial function in aging?. Exp Gerontol. 2016; 82:150-9. PMC: 4969173. DOI: 10.1016/j.exger.2016.06.008. View

4.
Hinson J, Medlin M, Lockman K, Taylor J, Mack C . Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors. Am J Physiol Heart Circ Physiol. 2006; 292(2):H1170-80. DOI: 10.1152/ajpheart.00864.2006. View

5.
Ansaldo A, Montecucco F, Sahebkar A, Dallegri F, Carbone F . Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol. 2018; 278:254-260. DOI: 10.1016/j.ijcard.2018.09.089. View